Connect with us
European Gaming Congress 2024

Fintech PR

Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth

Published

on

monument-therapeutics-secures-1m-investment-to-fund-its-schizophrenia-programme-and-drive-next-stage-of-growth

MANCHESTER, England, Oct. 15, 2024 /PRNewswire/ — Monument Therapeutics, a precision neuroscience company, today announced a further £1M equity investment by the Forster Foundation, a charitable incorporated organisation. The new investment builds on equity and non-dilutive funding announced in April 2024 and will support the clinical development of MT1988, a novel treatment for the cognitive symptoms of schizophrenia.  Cognitive impairment associated with schizophrenia significantly impact patients’ quality of life and presents a substantial unmet medical need and economic burden. Monument’s treatment MT1988 is complementary to existing drugs for schizophrenia, including the newly-approved drug Cobenfy, which was originally developed by Karuna Therapeutics and acquired by Bristol Myers Squibb last year for $14 billion.

Alongside this new investment, the company announced two new board appointments.

Dr Randeep Grewal, who has served as a board observer at Monument representing angel investors since 2022, has been appointed as board Chair. Randeep brings extensive experience from his other roles as Chair of Bellevue Healthcare Trust and non-executive director of organisations including Hox Therapeutics, the Global Smaller Companies Trust and the Monks Investment Trust. Furthermore, his previous background as a fund manager and a vascular surgeon provides a unique blend of financial and hands-on medical expertise. 

David Ford, an experienced life sciences investor and former Managing Director at Prudential Capital Group and Intermediate Capital Group, also joins the board, as a new Investor Director. David also serves as Chair of VisusNano Ltd and holds non-executive roles at Vianautis and Foresight VCT plc. “I am excited to join Monument Therapeutics at such an important stage in the company’s journey,” said David Ford. “The Company’s innovative approach to developing treatments for the cognitive symptoms of schizophrenia is both groundbreaking and much needed. I look forward to working with the team to help bring MT1988 through clinical development.”

“We are thrilled to welcome David to our board, during this pivotal moment for Monument Therapeutics growth strategy,” commented Dr Jenny Barnett, CEO of Monument Therapeutics. “The support from the Forster Foundation underscores the growing confidence in our precision neuroscience approach. This new investment will bring us closer to fulfilling our mission of improving the lives of people affected by schizophrenia and other psychiatric and neurological conditions.”

About Monument Therapeutics:

Monument Therapeutics applies a unique novel drug development strategy, leveraging digital assessments of cognition to match patients with new pharmaceutical treatments. Lead asset MT1988 targets the cognitive symptoms of schizophrenia, which are extremely costly for society and profoundly impact the affected individuals and their quality of life.

For more information, please visit www.monumenttx.com

For further information, contact:

Jenny Barnett, CEO
E-Mail: [email protected]

Advertisement

Media inquiries:

Christopher Koddermann
Tel: +41 (79) 434 25 78
E-Mail: [email protected]

 

Logo – https://mma.prnewswire.com/media/2504948/4965663/Monument_Therapeutics_Logo.jpg

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/monument-therapeutics-secures-1m-investment-to-fund-its-schizophrenia-programme-and-drive-next-stage-of-growth-302275080.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Hastee reaches profitability as Earned Wage Access solutions become the norm for top employers

Published

on

hastee-reaches-profitability-as-earned-wage-access-solutions-become-the-norm-for-top-employers

LONDON, Oct. 16, 2024 /PRNewswire/ — Hastee, one of Europe’s leading providers of earned wage access (EWA) and financial wellbeing solutions, is proud to announce that it has reached profitability. This marks a significant milestone in its journey to empower employees with greater financial flexibility and control. The achievement comes amid rising demand for on-demand pay solutions, with destination employers now frequently citing these as a necessary benefit to attract, retain, and engage staff.

Founded with a mission to improve the financial resilience of workers, Hastee has grown rapidly since its launch and now has over 350 employer clients spanning nearly all sectors. Notable customers include global leaders in hospitality (such as McDonald’s, Domino’s and Taco Bell), top international retailers (such as IKEA, Mediamarkt and DIA), major healthcare organisations (such as Bupa and the NHS), and many more of the world’s leading employers (such as Unilever, PayPal, Iberia Express and EY).

Hastee operates in 4 of the 5 largest European markets for earned wage access: UK, Spain, Ireland, and Portugal. In 2020, Hastee acquired Typs, one of Southern Europe’s leading financial wellbeing solutions, enabling Hastee to build a unique multi-language, multi-currency, and flexible platform ready for further international scaling. Hastee is majority-owned by IDC, a multi-fund platform with $2.2B AUM, through its innovation vertical IDC Ventures.

Hastee’s solution is built on 3 pillars of financial wellbeing: Earn, Learn, and Grow. Employees can use the award-winning Hastee app to track their earnings, access earned pay flexibly, receive personalized bite-sized financial education and save directly from their payroll. The app is one of the most popular financial wellbeing apps in the Apple App Store and Google Play Store, with a user rating of 4.7 in each. 

“We are extremely proud to be among the very first EWA providers globally to reach profitability,” commented Hastee CEO Jaime Jimenez. “The combination of rapid growth of our customer base alongside a cautious approach to spending has paid off: we have built a highly sustainable business that can service its clients without the need for further external funding.”

Jimenez continued: “Financial wellbeing has risen to the very top of the agenda among HR leaders, and we are honoured to have a role to play in supporting employees improve their financial health, while also helping our clients reach their ambitious ESG targets.”

“We are thrilled to support Hastee in reaching this pivotal moment,” shared Alejandro Rodriguez, co-founder and Managing Partner at IDC Ventures. “Hastee’s focus on financial wellbeing aligns perfectly with IDC Ventures’ mission of backing impactful companies that make a positive difference. We’re excited to be part of this journey, providing real value to both the end users and our partners. This achievement reflects the strength of Hastee’s model and the growing importance of solutions that empower individuals to take control of their financial health.”

About Hastee
Hastee is a financial wellness platform that allows employees to access a portion of their earned wages before payday, helping them manage cash flow and avoid debt. The platform integrates with employers’ payroll systems and provides users with flexible, on-demand access to their earnings. Hastee currently has over 350 employer clients spanning nearly all sectors. Learn more by visiting Hastee.com.

About IDC Ventures
IDC Ventures (IDCV) is a venture capital platform within IDC Network, a global multi-fund asset manager. Serving as the Partner of Choice for over 150 family offices across 30 countries, IDCV offers a diverse range of venture capital opportunities including proprietary funds, co-investments, and co-managed funds in collaboration with industry-leading managers. With $500M in assets under management, IDCV typically leads funding rounds and holds board seats, offering founders guidance drawn from deep expertise in entrepreneurship, banking, law, and consulting. Since its inception in 2019, IDCV has backed transformative founders from Series A to growth stages, with a primary focus on fintech and marketplaces in Europe, the US, and Latin America—particularly Brazil and Mexico. For more information, visit IDCVentures.com.

Media Contact: 
Ernesto Bernado
[email protected]

Advertisement
Hastee's logo

Photo – https://mma.prnewswire.com/media/2531083/jaime_hastee.jpg
Logo – https://mma.prnewswire.com/media/2531082/Hastee_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/hastee-reaches-profitability-as-earned-wage-access-solutions-become-the-norm-for-top-employers-302277028.html

Continue Reading

Fintech PR

Akastor ASA: Invitation to Presentation of Third Quarter 2024 Results

Published

on

akastor-asa:-invitation-to-presentation-of-third-quarter-2024-results

OSLO, Norway, Oct. 16, 2024 /PRNewswire/ — Akastor ASA invites investors and analysts to a webcast presentation of the third quarter 2024 financial results on Wednesday, 30 October 2024.

Date and time:
Wednesday, 30 October 2024, at 15:00 CET

Presenters:

  • Akastor: Karl Erik Kjelstad, CEO, and Øyvind Paaske, CFO
  • HMH: Thomas McGee, CFO, and David Bratton, SVP FP&A and Operational Finance

Link to webcast:
https://akercreativehub.eventcdn.net/events/akastor-audiocast-q3-2024

Questions can be submitted throughout the streaming event. The presentation material will be published on www.akastor.com and www.newsweb.no at 07:00 CET on 30 October.

For further information, please contact:

Øyvind Paaske
Chief Financial Officer
Mob: +47 917 59 705
E-mail: [email protected]

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/akastor-asa/r/akastor-asa–invitation-to-presentation-of-third-quarter-2024-results,c4051353

 

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/akastor-asa-invitation-to-presentation-of-third-quarter-2024-results-302277549.html

Continue Reading

Fintech PR

Greenbrook appoints Lord Hill and David Trenchard as Advisors

Published

on

greenbrook-appoints-lord-hill-and-david-trenchard-as-advisors

LONDON, Oct. 16, 2024 /PRNewswire/ — Greenbrook, the specialist communications advisor, is pleased to announce the appointment of former European Commissioner and Lead non-exec director at HM Treasury, Lord Hill, and the return of the City advisor, David Trenchard, as advisors to the firm.

Lord Hill is the former European Commissioner for Financial Stability, Financial Services and Capital Markets Union. He was Leader of the House of Lords and Chancellor of the Dutchy of Lancaster from 2013 to 2014. He has been Lead non-executive director at HM Treasury and is Chairman of the Ditchley Foundation. He carried out the UK Listings Review for the then Chancellor of the Exchequer in 2021.

David Trenchard, who was an advisor to Greenbrook from 2014 to 2022, brings over four decades of experience in finance. Most recently, he was Engagement Director at Elliott Advisors. David began his career at Morgan Stanley, rising to become a Managing Director in Equity Capital Markets and Head of Corporate Broking. 

Andrew Honnor, Managing Partner of Greenbrook, commented: “We are delighted to welcome both Jonathan and David to our team. Their considerable experience across policy, markets and finance will provide deep insight to our clients as they navigate the evolving challenges and opportunities in the current macro-economic environment.” 

Lord Hill commented: “I’ve known Andrew for two decades, and have looked with admiration at what he has achieved at Greenbrook. I look forward to joining his team and hope I can add something to the firm’s growing success.”

David Trenchard commented: “It is a pleasure to return as an advisor to Greenbrook, a leader in complex communications issues. I look forward to working with Greenbrook’s clients across various situations.”

Lord Hill and David Trenchard join Michelle Pinggera, Simon Walker and Piers Dennison as advisors to Greenbrook. Michelle joined Greenbrook in July 2018 and is the former International Chief of Staff and Partner at Goldman Sachs. Simon joined Greenbrook in March 2017 and was previously Director General of the Institute of Directors, Communications Secretary to HM Queen Elizabeth II, advisor to former Prime Minister John Major, and Chief Executive of the British Private Equity & Venture Capital Association. Piers joined Greenbrook in July 2021 and is a former Partner and Head of Investor Relations at Park Square Capital.

Contact details:

Ksenia Galouchko / Demi Kurban
Greenbrook
+44 20 7952 2000 / [email protected] 

About Greenbrook:

Advertisement

Greenbrook provides strategic communications advisory services to the investment industry. We work with clients across the following asset classes: private equity, venture capital, private debt, hedge funds, activist funds, infrastructure and real estate, and traditional fund management.

We advise our clients on all aspects of their business through the lens of reputation, helping to build and protect value.

Greenbrook has advised on over $58 billion of corporate and sovereign debt restructurings over the last 12 months. Greenbrook was ranked by Bloomberg as the #1 advisor in Europe for engaged shareholder communications in 2023. The firm ranked among the top #5 in Europe by Mergermarket and the #1 PR and communications firm in Europe by Private Equity Wire.

For more information, please visit www.greenbrookadvisory.com or follow Greenbrook on LinkedIn.

View original content:https://www.prnewswire.co.uk/news-releases/greenbrook-appoints-lord-hill-and-david-trenchard-as-advisors-302276721.html

Continue Reading
Advertisement
Advertisement European Gaming Congress 2024

Latest news

Trending